共 92 条
[1]
Riedl CC(2015)Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density J Clin Oncol 33 1128-1135
[2]
Luft N(2004)Surveillance of JAMA 292 1317-1325
[3]
Bernhart C(2011) and Invest Radiol 46 94-105
[4]
Warner E(2010) mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination J Clin Oncol 28 1450-1457
[5]
Plewes DB(2017)Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results Breast Cancer Res Treat 163 565-571
[6]
Hill KA(1979)Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial AJR Am J Roentgenol 132 737-739
[7]
Sardanelli F(2003)Breast cancer detection and tumor characteristics in Eur J Cancer 39 1770-1775
[8]
Podo F(2016) and Breast Cancer Res Treat 158 471-483
[9]
Santoro F(2004) mutation carriers Radiology 232 578-584
[10]
Kuhl C(1994)Breast cancer missed by mammography Radiology 191 241-244